Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Drug resistance
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Doctoral Thesis
(7)
+
-
Availability
Open access
(11)
+
-
Some under embargo
(1)
+
-
Metadata Only
(2)
+
-
Creation Date
2019
(4)
+
-
2018
(3)
+
-
2021
(2)
+
-
Faculty
Faculty of Science
(8)
+
-
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Dissertations
(7)
+
-
Leiden Academic Centre for Drug Research (LACDR)
(6)
+
-
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Leiden Institute of Chemistry (LIC)
(2)
+
-
Topic
Drug resistance
(14)
+
-
TNBC
(3)
+
-
CDK9
(2)
+
-
Targeted therapy
(2)
+
-
Transcriptional addiction
(2)
+
-
Author
He, J.
(3)
+
-
Assaraf, Y.G.
(2)
+
-
Besse, L.
(2)
+
-
Driessen, C.
(2)
+
-
Kraus, M.
(2)
+
-
McLaughlin, R.P.
(2)
+
-
Noord, V.E. van der
(2)
+
-
Water, B. van de
(2)
+
-
Zhang, Y.
(2)
+
-
Show more
Language
en
(14)
+
-
Search results
(1 - 14 of 14)
show grid
show list
save search
Disrupting the transcriptional machinery to combat triple-negative breast cancer
Cancer chess
Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer
FRET biosensor-based kinase inhibitor screen for ERK and AKT activity reveals differential kinase dependencies for proliferation in TNBC cells
Nelfinavir interacts with mitochondrial VDACs and disrupts oxidative phosphorylation in proteasome inhibitor resistant myeloma
Uncovering vulnerabilities in triple-negative breast cancer
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Targeted therapy for triple-negative breast cancer
Using insertional mutagenesis to identify breast cancer drivers and therapy resistance genes in mice = Insertie mutagenese voor het identificeren van genen betrokken bij de ontwikkeling van borsttumoren en therapie resistentie in muizen
Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
The novel beta 2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Enhancement of host defense against pathogens by antimicrobial peptides : a new approach to combat microbial drug resistance
Infection control in Indonesian Hospitals